Teleflex (NYSE:TFX) Reaches New 12-Month Low – What’s Next?

Shares of Teleflex Incorporated (NYSE:TFX) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $101.01 and last traded at $101.04, with a volume of 73510 shares trading hands. The stock had previously closed at $103.00.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Zacks Research lowered Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Wells Fargo & Company upped their price target on shares of Teleflex from $114.00 to $139.00 and gave the stock an “equal weight” rating in a research report on Wednesday, December 10th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Finally, Truist Financial raised their price target on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a report on Thursday, December 18th. One research analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Teleflex has a consensus rating of “Reduce” and an average price target of $142.43.

Teleflex Price Performance

The company has a quick ratio of 1.53, a current ratio of 2.57 and a debt-to-equity ratio of 0.67. The company has a 50 day simple moving average of $116.83 and a 200-day simple moving average of $120.48. The stock has a market cap of $4.49 billion, a price-to-earnings ratio of -13.84, a PEG ratio of 1.34 and a beta of 0.93.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. The business had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The business’s quarterly revenue was up 19.4% on a year-over-year basis. During the same period in the previous year, the business earned $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date was Friday, November 14th. Teleflex’s dividend payout ratio (DPR) is presently -18.50%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. MassMutual Private Wealth & Trust FSB lifted its position in Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 77 shares during the period. Hantz Financial Services Inc. raised its holdings in shares of Teleflex by 248.8% during the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 199 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Teleflex during the third quarter valued at approximately $35,000. True Wealth Design LLC increased its position in Teleflex by 10,333.3% in the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock worth $37,000 after buying an additional 310 shares during the period. Finally, Quent Capital LLC acquired a new position in shares of Teleflex during the third quarter worth approximately $38,000. 95.62% of the stock is currently owned by institutional investors.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.